$NEOG

NEOGEN CORP (NEOG): Submission of Matters to a Vote of Security Holders

NEOGEN CORP (NEOG) filed an SEC Form 8-K — Submission of Matters to a Vote of Security Holders. Item 5.07 Submission of Matters to a Vote of Security Holders. On October 1, 2026, the Company held its 2026 Annual Meeting of Shareholders. At the meeting, 176,180,487 of the 218,106,005 shares outstanding and entitled to vote were present and voted. The matters listed below wer

Original reporting
Published Oct 7, 2026, 12:55 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 7, 2026, 1:00 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefCorporate actions
Primary signal
$NEOG
Neutral
low confidence
Mentioned
$NEOG
Relevance
6/10
AlphAI data visualization · based on SEC EDGAR 8-K
Decision brief

The 30-second read

$NEOGNeutralLow
01

Why it matters

The filing is a routine corporate governance disclosure with minimal market impact.

02

Market read

Low relevance; standard proxy vote results unlikely to move the stock.

03

What to watch

None; the vote results do not affect earnings or guidance.

Relevance 6/10Novelty 2/10Timing: same day

Background

Neogen Corp (NEOG) filed a Form 8‑K detailing the outcomes of its 2026 annual shareholders meeting, including director elections, executive compensation advisory vote, auditor ratification, and plan amendments.

Company-level read

Ticker impact

$NEOGNeutralLow confidence
Context

SEC 8‑K filing reports the annual shareholder meeting vote results and proxy approvals for Neogen Corp.

Expected impact

neutral as the results are expected and do not alter valuation

Evidence & confidence

The filing confirms standard governance actions; no new financial data or strategic shift is disclosed.

Market effects

none

none

none

Counterpoint

No contrarian angle; the filing is purely procedural.

Key entities

  • Neogen Corp

    US‑listed biotech firm (ticker NEOG) reporting its annual shareholder meeting results.

Related articles

$NEOGLow

Neogen Outlines Strategy for Growth, Innovation and Margin Expan

Neogen Corporation (NEOG) outlined its growth strategy at its 2026 Investor Day, targeting high-single-digit to low-double-digit revenue growth, high-50% adjusted gross margin, and 30% adjusted EBITDA margin by FY2031. The company plans to increase R&D investment by 50% in FY2027, aiming for $100M in incremental revenue from new products by FY2031. Neogen also highlighted its data platform, Neogen Analytics, as a key driver of recurring revenue and customer retention.

$NEOGHighAI 8/10

Why Are Neogen (NEOG) Shares Soaring Today

Neogen (NEOG) shares rose 14.1% premarket after Q3 2026 results beat expectations, with revenue up 6.5% YoY to $222.8M. The company raised full-year guidance, citing strong growth in indicator testing and Petrifilm. Shares later cooled to $11.79, down 1.7% from the previous close.

$NEOGMed

Neogen (NEOG) Q1 2027 Earnings Call Transcript

Neogen (NEOG) reported Q1 2027 revenue of $222.8M, up 8.1% year-over-year, driven by commercial excellence. Food Safety segment revenue was $163.2M, with 8.1% core growth. The company is investing in innovation, technology, and operational efficiency to drive long-term growth and margin expansion. Key initiatives include commercial prowess, high-impact innovation, and operational excellence.

$NEOGHigh

Neogen Q1 Revenue Rises 6.5%; Raises FY27 Outlook

Neogen Corp. (NEOG) reported a 6.5% revenue increase to $222.8M in Q1 FY27, with an adjusted net income of $17.5M. The company raised its FY27 revenue guidance to $885M-$890M and adjusted EBITDA to $181M-$183M. It also announced a collaboration with Hinalea Imaging and plans to sell its Genomics business to Zoetis Inc.